Other
FB101
FB101 is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (50.0%)
N/A2 (50.0%)
Trials by Status
not_yet_recruiting125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)
NCT05850078
not_yet_recruitingphase_1
A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
NCT07126704
completednot_applicable
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis
NCT05114031
completedphase_1
Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
NCT04165837
Clinical Trials (4)
Showing 4 of 4 trials
NCT05850078Not Applicable
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)
NCT07126704Phase 1
A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
NCT05114031Not Applicable
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis
NCT04165837Phase 1
Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4